Establishing a core domain set to measure rheumatoid arthritis flares: report of the OMERACT 11 RA flare Workshop - Test2 - elhamkhani - TriplyDB

Establishing a core domain set to measure rheumatoid arthritis flares: report of the OMERACT 11 RA flare Workshop

Establishing a core domain set to measure rheumatoid arthritis flares: report of the OMERACT 11 RA flare Workshop

http://www.wikidata.org/entity/Q26859493

about

Patient reported outcomes in rheumatoid arthritis clinical trials Improving inflammatory arthritis management through tighter monitoring of patients and the use of innovative electronic tools Feasibility and Domain Validation of Rheumatoid Arthritis (RA) Flare Core Domain Set: Report of the OMERACT 2014 RA Flare Group Plenary International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials Evaluation of the Disease Activity Score in Twenty-Eight Joints-Based Flare Definitions in Rheumatoid Arthritis: Data From a Three-Year Clinical Trial.On the translocation of bacteria and their lipopolysaccharides between blood and peripheral locations in chronic, inflammatory diseases: the central roles of LPS and LPS-induced cell death.More than Just Minutes of Stiffness in the Morning: Report from the OMERACT Rheumatoid Arthritis Flare Group Stiffness Breakout Sessions Systematic review of the methodological quality of controlled trials evaluating Chinese herbal medicine in patients with rheumatoid arthritis.Identifying flares in rheumatoid arthritis: reliability and construct validation of the OMERACT RA Flare Core Domain Set Successful Stepwise Development of Patient Research Partnership: 14 Years' Experience of Actions and Consequences in Outcome Measures in Rheumatology (OMERACT).Patient-reported outcomes in core domain sets for rheumatic diseases.Incorporating the patient's perspective in outcomes research.Development and testing of candidate items for inclusion in a new rheumatoid arthritis stiffness patient-reported outcome measure.Health Equity Considerations for Developing and Reporting Patient-reported Outcomes in Clinical Trials: A Report from the OMERACT Equity Special Interest Group.Neutrophil-to-lymphocyte ratio is a reliable marker of treatment response in rheumatoid arthritis patients during tocilizumab therapy.Validation of FLARE-RA, a Self-Administered Tool to Detect Recent or Current Rheumatoid Arthritis Flare.Sleep disturbance in patients with rheumatoid arthritis is related to fatigue, disease activity, and other patient-reported outcomes.Discontinuation of etanercept after achievement of sustained remission in patients with rheumatoid arthritis who initially had moderate disease activity-results from the ENCOURAGE study, a prospective, international, multicenter randomized study.The revised Bristol Rheumatoid Arthritis Fatigue measures and the Rheumatoid Arthritis Impact of Disease scale: validation in six countries.Impact of patient-reported flares on radiographic progression and functional impairment in patients with rheumatoid arthritis: a cohort study based on the AMBRA trial.What constitutes back pain flare? A cross sectional survey of individuals with low back pain.No clear association between ultrasound remission and health status in rheumatoid arthritis patients in clinical remission.Patient-self assessment of flare in rheumatoid arthritis: translation and reliability of the Flare instrument.Targeting lymphatic function as a novel therapeutic intervention for rheumatoid arthritis.Call for action: how to improve use of patient-reported outcomes to guide clinical decision making in rheumatoid arthritis.Mental health, fatigue and function are associated with increased risk of disease flare following TNF inhibitor tapering in patients with rheumatoid arthritis: an exploratory analysis of data from the Optimizing TNF Tapering in RA (OPTTIRA) trial.

P2860

Q26852960-9ADE5DB1-EFBB-4A91-B79F-21BBB5B82720 Q28071252-22ABE2F2-1A28-4B20-8ADF-8D2DB58DF71D Q28081736-06EFCDD5-26E8-481A-B6DF-9B0E914D6C3B Q30841346-560A3CDA-6E48-41E8-913A-351BAC9D8582 Q30964201-2D96E02B-4AF6-45A4-AD85-E07FD9D4981B Q35765830-9385A65C-D343-48C3-BA38-170CEAC10402 Q36016854-25862878-6148-465F-B1DE-5F81158A7B46 Q36294542-625E21C6-0250-4463-AAD5-967818CF83EC Q36947638-48897B13-C0D3-4DC4-9089-BB44CF90BB20 Q37716844-EDAB4293-278D-4AB2-823D-B376866511DF Q38577796-7062FF67-5330-4552-9974-1FED2454EBDE Q38772280-30DA95B0-CB63-4DA8-A4BE-CC887073A43C Q38838252-1D10FB24-CCA7-46AB-9C4F-871F5BF359A2 Q39137421-7B7A2459-1AAD-4317-83AE-C0850CC50F85 Q39337664-2C33698D-A17D-4097-9606-8888D9E267AC Q39381766-7AC26A2C-3D51-4ECB-97FE-411581CDCDC9 Q39672360-066CF334-91F4-402B-8A0B-2D9F51B81BBC Q40859479-C86BE673-E662-4D73-B720-5D868DE37F28 Q47594110-49755C93-1E93-4691-A8A2-05F0DB193BFF Q47659402-CE523A99-C655-4009-A34E-A3D7D0A36804 Q47713960-F0F8B5EA-F3DA-4ACB-85A8-F613ABA9E1C7 Q47916785-50993F43-EB36-4D8A-B015-ED1D22777680 Q48046367-A3EE8521-8F27-4C75-B0F4-19E21A1FE2D6 Q48542106-46C891A7-F9B2-45B0-8863-D6A9F18DE65B Q52807047-E4003152-051F-4575-985D-203FFF826EBB Q55223606-B71E1CEE-872A-492A-93AC-828E16797274

P2860

Establishing a core domain set to measure rheumatoid arthritis flares: report of the OMERACT 11 RA flare Workshop

http://www.wikidata.org/entity/Q26859493

description

2014 nî lūn-bûn

@nan

2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Establishing a core domain set ...... e OMERACT 11 RA flare Workshop

@ast

Establishing a core domain set ...... e OMERACT 11 RA flare Workshop

@en

Establishing a core domain set ...... e OMERACT 11 RA flare Workshop

@nl

type

label

Establishing a core domain set ...... e OMERACT 11 RA flare Workshop

@ast

Establishing a core domain set ...... e OMERACT 11 RA flare Workshop

@en

Establishing a core domain set ...... e OMERACT 11 RA flare Workshop

@nl

prefLabel

Establishing a core domain set ...... e OMERACT 11 RA flare Workshop

@ast

Establishing a core domain set ...... e OMERACT 11 RA flare Workshop

@en

Establishing a core domain set ...... e OMERACT 11 RA flare Workshop

@nl

P1433

Q26859493-21275479-E144-4294-92E7-52120AEBFFCE

P1476

Q26859493-CC22C83F-17E5-41D6-A9FF-32340617F361

P2093

Q26859493-086929BC-73C6-4E6F-A15C-FF47184E489B

Q26859493-19970605-0C97-4B9F-9225-53112A5664A6

Q26859493-2A2F882C-3717-49F0-9416-93C419CF6543

Q26859493-31C39EBE-C4CE-470A-904F-80723F8F1F4A

Q26859493-3798F4E9-978A-4F6D-8F24-79AF1222640E

Q26859493-4960EFD7-CAD3-4A0A-852B-D913B9AE4A84

Q26859493-4ABA4061-00A6-4A73-A585-9ACFE2C7EF52

Q26859493-4EE0AAAF-B6FB-4925-8772-9AEF0A105A05

Q26859493-4EF5EEA2-640E-4DC2-BDC8-54E4CC6BFC6A

Q26859493-5D2C8057-8138-4F97-A5C2-1CC4545E88DF

P2860

Q26859493-0C46FE43-BF4E-4C23-BFBE-2BB4BD3FA02D

Q26859493-13CCBB8C-9481-4B8B-91FE-338F77F7D60B

Q26859493-17E7C948-619D-4B77-825C-A64F4BB7B13B

Q26859493-1FC5184A-0744-4EE4-967C-B27FEC883C66

Q26859493-20F564CD-E486-4393-8BD7-2C66A9BA6DC3

Q26859493-2671D166-F371-4A4A-B47F-8B4E7490F9F5

Q26859493-29035705-AEB1-4E17-B783-99ABF9A9FE13

Q26859493-2CFB980F-13BC-4D07-969B-8BAE6FC20F91

Q26859493-2D2D1F17-1E8A-4C99-9C82-CD0E1FD2D792

Q26859493-4A8A116C-27EA-414B-B014-E9BAEF1AFD1B

P304

Q26859493-BEC43A5A-A952-4C9F-BAB9-7595AA2C7CF1

P31

Q26859493-4FEFBBAD-2CC6-4B75-9E13-18007271317C

P3181

Q26859493-BFA61F70-6FCB-44F6-91F2-38EE57C8BEC0

P356

Q26859493-C1213CAD-7DCD-40EB-8CF0-A7E6DAE6A986

P407

Q26859493-437E8880-4C28-4DA0-9174-5AB7461F76D1

P433

Q26859493-FF1C3A97-2022-4703-80C8-C9E9777C943F

P478

Q26859493-4A0FEC73-8514-42BA-AC8A-5F12C11752D1

P50

Q26859493-9CB04F54-EE81-4763-AABF-DF0C4716876D

Q26859493-A9708DA5-A2D5-49CF-9327-11428B14A925

P577

Q26859493-A5CAA418-479B-4632-B81B-151871CAC436

P5875

Q26859493-6B7AE36A-311A-4177-9C0D-F2C64A3B455A

P698

Q26859493-FB9A034C-5F82-440E-9715-C2016F4BC214

P921

Q26859493-A0394D28-67AF-46B0-A42F-64BD13510E39

P932

Q26859493-93232FFC-79A2-46BC-8724-AB95431D6911

P3181

P356

P1433

The Journal of Rheumatology

P1476

Establishing a core domain set ...... e OMERACT 11 RA flare Workshop

@en

P2093

Amye L Leong

http://www.w3.org/2001/XMLSchema#string

Anne Lyddiatt

http://www.w3.org/2001/XMLSchema#string

Annelies Boonen

http://www.w3.org/2001/XMLSchema#string

Christoph Pohl

http://www.w3.org/2001/XMLSchema#string

Clifton O Bingham

http://www.w3.org/2001/XMLSchema#string

Daniel E Furst

http://www.w3.org/2001/XMLSchema#string

Elisabeth Lie

http://www.w3.org/2001/XMLSchema#string

Ernest H Choy

http://www.w3.org/2001/XMLSchema#string

James E May

http://www.w3.org/2001/XMLSchema#string

Lyn March

http://www.w3.org/2001/XMLSchema#string

P2860

2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis

Updating the OMERACT filter: core areas as a basis for defining core outcome sets

Patient perspective of measuring treatment efficacy: the rheumatoid arthritis patient priorities for pharmacologic interventions outcomes.

Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations.

Guidelines for the process of cross-cultural adaptation of self-report measures.

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

Treating rheumatoid arthritis to target: recommendations of an international task force.

Principles of Good Practice for the Translation and Cultural Adaptation Process for Patient-Reported Outcomes (PRO) Measures: report of the ISPOR Task Force for Translation and Cultural Adaptation.

Low-dose prednisone chronotherapy for rheumatoid arthritis: a randomised clinical trial (CAPRA-2)

Determinants of discordance in patients' and physicians' rating of rheumatoid arthritis disease activity

P304

799-809

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1245705

http://www.w3.org/2001/XMLSchema#string

P356

10.3899/JRHEUM.131252

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

41

http://www.w3.org/2001/XMLSchema#string

P50

Susan J. Bartlett

Ana-Maria Orbai

P577

2014-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260446253

http://www.w3.org/2001/XMLSchema#string

P698

24584927

http://www.w3.org/2001/XMLSchema#string

P921

P932

4365895

http://www.w3.org/2001/XMLSchema#string